ARCHIVES
CERN News 2017 - MEDICIS a new CERN facility
CERN Press release 2017 - MEDICIS une nouvelle installation du CERN
MEDICIS-Promed: from fundamental research to hospitals
MEDICIS is restarting after the COVID outbreak
CERN Women In Technology (WIT) Photo Session
PRISMAP: The European medical isotope programme, a consortium with the principal medical radionuclides providers - including MEDICIS - was submitted yesterday for funding by the European Commission; feedback expected after the summer. Link there.
Dr S. Stegemann (ESR-11) receives the Prijs Wetenschap & Innovatie (Prize Science & Innovation) for his PhD thesis from the Faculty of Science of KU Leuven.
CERN-courrier article: MEDICIS shows its stength - link there.
PRISMAP-The European medical isotope programme has been selected ! More information there.
- 01/02/2021
We are welcoming Edgars Mamis from Latvia University, one of the few first PhD students from Latvia at CERN.
- 04/02/2021
Is the World Cancer Day ! At this occasion, MEDICIS' involvement in the fight against cancer is presented on CERN's official website together with a video of our unique facility.
- 07/06/2021
MEDICIS is re-starting with a period of maintenance and upgrade !
- 08/07/2021
Pr. Thomas Cocolios (KU Leuven) receives the "Roger Van Geen" chair! More information here
- 14/07/2021
Nhat-Tan Vuong (ESR-2) defended his PhD thesis. Congratulations! More information here.
- 15/07/2021
The article "CERN-MEDICIS: a review since commissioning in 2017" is now published! More information here.
- 23/09/2021
PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.
- 29/11/2021
The 1st call for user projects of PRISMAP is launched! More information here.
- 04/02/2022
World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.
-
02/05/2022
MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.
- 27/05/2022
Plenary presentation on new developments exploiting isotope mass separation in nuclear medicine presented at the 1st AccConf'22 at IAEA.
- 15/06/2022
1st projects have been selected in PRISMAP-The European medical isotope programme.
-
06/09/2022
A third collaboration meeting took place today in the French ANR project REPARE, to review the progresses on the development of a high power Bi target for the production of At-211.
- 26/09/2022
The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.
- 15/11/2022
The Frontiers Research Topics : MEDICIS-Promed, Advances in Radioactive Ion Beams for Nuclear Medicine is now published. It can be downloaded from there.
- 10/03/2023
Three new project proposals were submitted at the 10th MEDICIS Collaboration board, with a notable request to translate one of the MEDICIS High Molar Activity radionuclides in a clinical settings.
- 16/05/2023
Recent technical developments such as the online activity monitoring during implantation and the definition of Key Performance Indicators for MEDICIS were reported at EMIS2022 and IPAC2023 conferences. Related EMIS and IPAC publications.
- 06/2023
MEDICIS recent achievements have been presented during invited presentations at the ARIS2023 conference (Avignon, France) and the 16th conference on nuclear reaction mechanisms (Varenna, Italy)
